BC
TMO icon

Barrett & Company’s Thermo Fisher Scientific TMO Stock Holding History

Barrett & Company’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
271
+140
+107% +$67.2K 0.04% 204
2026
Q1 		$64.4K Hold
131
– – 0.02% 262
2025
Q4 		$75.9K Hold
131
– – 0.03% 243
2025
Q3 		$63.5K Sell
131
-122
-48% -$56.8K 0.02% 267
2025
Q2 		$103K Buy
253
+200
+377% +$83.6K 0.04% 206
2025
Q1 		$26.4K Hold
53
– – 0.01% 345
2024
Q4 		$27.6K Buy
+53
New +$29.1K 0.01% 343
2024
Q3 		– Sell
-120
Closed -$66.4K – 608
2024
Q2 		$66.4K Buy
120
+25
+26% +$14.3K 0.03% 235
2024
Q1 		$55.3K Buy
95
+10
+12% +$5.61K 0.03% 259
2023
Q4 		$45.2K Hold
85
– – 0.02% 265
2023
Q3 		$43.1K Hold
85
– – 0.03% 258
2023
Q2 		$44.4K Buy
85
+10
+13% +$5.4K 0.03% 262
2023
Q1 		$43.3K Buy
75
+15
+25% +$8.45K 0.03% 253
2022
Q4 		$33.1K Hold
60
– – 0.02% 263
2022
Q3 		$33.1K Buy
+60
New +$33.6K 0.02% 263

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Barrett & Company's TMO Position: Q2 2026 in Review

Barrett & Company increased its Thermo Fisher Scientific (TMO) stake by 107% in Q2 2026, buying an estimated $67.2K and bringing the position to 271 shares worth $136K. The position accounts for 0.04% of the portfolio, ranked #204.

Barrett & Company first reported a position in TMO in Q3 2022 and has held it in 15 quarters since. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Barrett & Company held 271 shares of Thermo Fisher Scientific worth $136K as of Q2 2026.
  • Barrett & Company bought 140 Thermo Fisher Scientific shares in Q2 2026, an estimated $67.2K.
  • Thermo Fisher Scientific made up 0.04% of Barrett & Company's portfolio in Q2 2026, its #204 holding.
  • Barrett & Company first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 15 quarters since.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.